CAS RN: 178312-02-2
4-(azetidin-3-yl)thioMorpholine 1,1-dioxide
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 178312-02-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
178312-02-2 / 4-(azetidin-3-yl)-1,4-thiazinane 1,1-dioxide;dihydrochloride
Standard CAS: 178312-02-2
Multi CAS: No
Basic Information
copy
CAS
178312-02-2 copy
Multi CAS
No copy
Molecular Formula
C7H16Cl2N2O2S copy
Molecular Weight
263.180000 copy
Exact Mass
262.030954 copy
SMILES
C1CS(=O)(=O)CCN1C2CNC2.Cl.Cl copy
InChI
InChI=1S/C7H14N2O2S.2ClH/c10-12(11)3-1-9(2-4-12)7-5-8-6-7;;/h7-8H,1-6H2;2*1H copy
InChIKey
AXHOLMAQHXNIGR-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
14 copy
Fraction Csp3
1 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
H-bond donors
1 copy
Molar refractivity
61.38 copy
TPSA
49.41 copy
LogP / Solubility
WLOGP
-0.47 copy
MLOGP
-0.4 copy
XLogP3
-0.47 copy
Consensus LogP
-0.45 copy
Log S (ESOL)
-1.11 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.38 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.1 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
Low copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.66 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy